Introduction

Viruses are the most common intracellular pathogens that cause deadly infectious diseases and surround us everywhere in wildlife. Every year, with enviable regularity, humanity is faced with great and little-known danger, threatening all of us with epidemics and the death of a large number of people. According to a 2018 report by the World Health Organization, over 37.6 million people are infected with the human immunodeficiency virus (HIV) and to date, this virus has claimed more than 32 million lives [https://www.who.int/ru/news-room/fact-sheets/detail/hiv-aids]. People are constantly threatened by many other and emerging viruses that cause the highly pathogenic avian influenza virus, influenza A subtype (H5N1 [1] and H7N9 [2]), severe acute respiratory syndrome coronavirus [3], the Ebola virus [4], the Middle East respiratory coronavirus syndrome [5]. Today the ranks of these economically and socially dangerous infections have been replenished with another one - COVID-19, with more than 4.5 million deaths registered worldwide [https://apps.who.int/iris/bitstream/handle/10665/331685/nCoVsitrep01Apr2020-eng.pdf]. Respiratory infections are of global importance, and the last two years have shown the particular importance of research work aimed at finding effective antiviral drugs, since the emergence of new viruses [3,4,5] and drug-resistant virus strains [6] has been a continuous process, leading to outbreaks and pandemics. A particularly high mutation rate is observed in viruses that cause severe acute respiratory syndrome, including all types of influenza viruses [7, 8], and coronaviruses [3, 5].

Influenza causes annual epidemics that quickly spread from country to country, involving in severe cases (pandemics) a significant part of the world’s human population [9]. Despite the advances made in the field of chemotherapy, vaccination, and immunology of influenza, it remains a difficult-to-control infection due to high genetic variability and various long-term complications after the acute stage, leading to “latent” or secondary mortality caused not by the influenza virus itself, but by virus-induced secondary processes [10]. The rapid development of resistant variants of influenza reduces the effectiveness of the anti-influenza properties of active substances; therefore, the search for new compounds with antiviral properties is an extremely important objective of high priority.

Chemical compounds isolated from plants are widely used in many different areas of activities that are successfully used in pharmacotherapy [11]. The flora land is rich in medicinal herbs and plants, which contain biologically active components providing the main pharmacological action. A significant part (about 24.4%) of these metabolite compounds are triterpenes [12]. Among them, tetracyclic and pentacyclic triterpenes as well as their semisynthetic derivatives possesses a wide spectrum of biological activity, including antitumor, antimicrobial, antiparasitic, antibacterial, anti-inflammatory, and hepatoprotection action [13, 14].

The antiviral activity of this class of compounds also has a fairly wide spectrum. Triterpenes are active against viruses such as human immunodeficiency viruses, hepatitis B and C, various types of influenza viruses, acute respiratory viral infections, herpes viruses, human enterovirus, Epstein-Barr, and Zika viruses [15, 16]. The potential of triterpenoids as antiviral platforms is very promising. This is evidenced by such good examples as bevirimat - an anti-HIV drug derived from a betulinic acid [17], glycyrrhizinic acid—a native platform used for the treatment of chronic hepatitis [18]. Recently, 3-O-β-chacotriosyl oleanolic acid benzyl ester has been identified as a novel low molecular weight inhibitor of the SARS-CoV-2 virus [19]. Therefore, research in this area is very actual and should be extensively continued.

All of the above, in particular the ability of the virus to develop resistance to antiviral drugs, indicates the need to search and develop effective and cheap anti-influenza agents with a wider spectrum of action based on plant metabolites and their semisynthetic derivatives. Since often, the activity of chemically modified compounds is not inferior to and sometimes exceeds the activity of native compounds [20].

In this context, in a continuation of our research in the field of antiviral properties of semisynthetic triterpene derivatives [21,22,23,24], a synthesis and an antiviral activity screening of a series of lupane, oleanane, and dammarane types amino-triterpenoids against the H1N1 influenza virus have been performed.

Results and discussion

The literature data showed that nitrogen-containing derivatives of triterpenoids in A-ring led to an increase of antiviral activity, in particular, anti-influenza activity [25]. These results include mostly oxime and amide functions at C3 or C28 positions. For example, 3-oxime of betulonic acid and L-leucine-28-amide demonstrated 90% suppression of influenza virus A H7N1 (EC50 2.17, MTT/EC50 392.16) [26, 27] 3β- and 3α-amino-derivatives of oleanolic acid possessed inhibitory activity on HCV protease [28].

Alnincanone having a framework of dammarane, echinocystic acid—lupane type triterpenoid, and methyl ester of ursolic acid possess pronounced inhibiting activity against influenza type A virus (protection index 60%) and high antiviral activity against influenza type B (protection index 80%) [29]. 3-Cyanoethoxy derivatives of dammarane triterpenoids alnincanone and dipterocarpol, 3-tetrazolyl derivative of dammarolide had a considerable activity with SI 10, 9, and 26 against influenza virus A/Puerto Rico/8/34 (H1N1) [30].

The presence of the seven-membered azepane fragment in cycle A in various types of triterpenoids leads to an increased native and occurrence of new types of biological activity. Azepanotriterpenoids are the promising compounds toward M. tuberculosis [31], ESCAPE pathogens [32, 33], and HSV-1 [33].

Taking in mind that to combine amino-function with the seco fragment in the A cycle of triterpenoids is also an effective direction in the search for antiviral platforms we have shown that lupane 3,4-seco-3,28-bis-N,N-methylpiperazine-amide has IC50 27 μM and SI 7.1 against Flu A H1N1 strain [34]. A lupane 2,3-seco aldehydoacid, diacid, 3-aldoxime derivatives can suppress the reproduction of HSV-1 and Flu A (EC50 from 0.06 to 21.3 μM) [35, 36]. Ethyl β-alaninate diamide 2,3 seco-lupane was shown to combine antiherpetic (EC50 4.1 μM) and anti-HIV activity (EC50 5.1 μM) [37] and C-28 amide conjugate with a 2-aminpropane-1,3-diol was the most active compound against herpes simplex virus type I (5.7 μM, MTC/EC50 32.2) [38]. Inhibition of the serotype A viruses with a protection index of 60% by 2,3- and 3,4-seco-dammarane acids was reported in [39].

Based on our previous reports on the antiviral activity of nitrogen-containing triterpenoids [21,22,23,24, 34, 40] and considering the pronounced anti-influenza activity of lupane, oleanane, and dammarane triterpenoids in this work we focused our attention on a synthesis of a series of this type triterpenoids with 3β-amino, A-ring azepano- and 3,4-seco-3-amino-fragments and their evaluation against influenza H1N1 type. Need to note that semisynthetic dammarane triterpenoids have been a few studied against influenza viruses and search for new antiviral platforms based on this type of triterpenoids are a relevant direction.

Chemistry

As was mentioned above, the triterpenes and their nitrogen derivatives demonstrated activity against different strains of the influenza virus.

The three series of A-ring nitrogen-containing derivatives with 3β-amino, azepano- and 3-amino-3,4-seco-fragments have been designed and synthesized. These compounds are presented by new 4–6, and 8 (Scheme 1) and previously synthesized 9–19 (Fig. 1) triterpenoids.

Scheme 1
scheme 1

Synthesis compounds 4–8: a. CH3COONH4, NaBH3CN, CH3OH, 22 °С, 12 h; b. NH2OH HCl, Py, reflux; c. SOCl2, dioxane, 22 °C, 30 min; d. LiAlH4, THF, reflux, 3 h. The parent compounds were described in 1 [41], 2 [42], dipterocarpol 3 [43]

Full size image
Fig. 1
figure 1

The structures of compounds 9 [46], 10 [47], 11 [48], 12 [49], 13, 16, 18, 19 [50], 15 [51], 14 [52], 17 [53]

Full size image

Reduction amination was applied to prepare compounds with a free amino group at C3. The reaction of 3-oxoderivatives betulonic acid cyclohexylamide 1 [41], oleanonic 2-aminopyridine-amide 2 [42] and dipterocarpol 3 [43] with ammonium acetate in presence of NaBH3CN in methanol at room temperature lead to compounds 4–6 with yields of 82–89% after purification by column chromatography. Early compound 6 was isolated from a plant Astragalus genus [44]. The structures of compounds 4–6 were confirmed by spectroscopic methods (see Supplementary material S1–S9). In the 13C NMR spectra, the signals of the C3 carbon atom at the amino group were detected at δC 56.60–59.74 ppm, in the 1H NMR spectra Hα-3 proton signals resonated at δH 2.20–2.72 ppm as a doublet of doublets.

The presence of NH2-group at C3 position of compound 6 is confirmed by cross peaks of nearby protons (Heq-2, H-3) in the {1H, 15N} HMBC spectrum with amino-nitrogen at δN ~31 ppm (Fig. 2). The stereochemistry of the chiral center at C3 was established using analysis of NOESY spectra and coupling constants of compound 6. Signal splitting of H-3 (δH 2.34 ppm) with coupling constants of 11.8 and 4.1 Hz indicates its axial position. The key signals for the configuration assignment are NOESY cross-peaks H-3 with H-5 and Hax-1 protons which are indicative of both axial alignment of the proton at C-3 and its α-configuration, which is confirmed the data [45].

Fig. 2
figure 2

Key NOESY, HMBC, and COSY correlations of compound 6

Full size image

The treatment of dipterocarpol 3 with NH2OH·HCl in pyridine according to [43] and following Beckmann rearrangement of the crude oxime with thionyl chloride in dioxane at room temperature led to azepanone 7 (82%), the following reduction with LiAlH4 in THF afforded azepano-20(S)-hydroxy-dammar-24-en 8 (85%). The structures of the target compounds were confirmed by NMR data. The presence of amide fragment in azepanone 7 was confirmed by the characteristic signal of C3 carbonyl carbon which was detected at δ 176.29 ppm. In the 13C NMR spectrum of azepane 8, the upfield shift of the carbonyl signal C3 to region δ 63.11 ppm was observed. In the 1H NMR spectra, the signal of methylene protons at C3 atom was registered at δ 3.19 ppm.

Thus, new amino-triterpenoids 4–6 and 8 have been synthesized for biological screening.

Biological activity

Evaluation of antiviral activity

Cytotoxicity and anti-influenza properties of the derivatives 4–6 and 8–19 were studied in MDCK cell culture against influenza virus A/PuertoRico/8/34 (H1N1) Oseltamivir carboxylate was used as a reference compound. All results are summarized at Table 1. As one can see, the tested compounds were of relatively high cytotoxicity their CC50’s lying in one- to two-digits micromolar range. It was shown, in particular, that modification of the C-28 position of lupane triterpenoids with the introduction of a cyclohexylamine substituent in compound 4 leads to a decrease in cytotoxicity by 1.7 times compared to 3β-amino-olean-28-oate 9 containing a methoxy fragment. A similar situation is observed for amide 13, which is 13 times less toxic in comparison with azepanobetulin 12. Among the derivatives of the oleanane series, azepanoallobetulin 14 showed the lowest toxicity with CC50 46.7 μM. The azepenouvaol 15 is the most toxic compound among all studied (CC50 0.1 μM), but transformation of ring A on 3,4-seco-3-amino in derivative 18 decreased toxicity by 200-fold. The broadening of ring А from six-membered with 3-amino function to seven-membered azepane in dammarane type derivatives one results in some decrease of toxicity (compound 6 and 8) from 13.5 to 21.9 μM.

Table 1 The antiviral activity of compounds 4–6 and 8–19 against Flu A H1N1
Full size table

For lupane, oleanane, and dammarane type derivatives 4–6 and 9–11 with the 3β-amino group at C3 position the SI against H1N1 virus ranged from 1 to 10. 3β-Amino-28-oxo-allobetulin 11 with IC50 2.6 μg ml–1 and SI 10 was established as the most active compound in this series.

Taking into account the potency of azepenotriterpenoids as biologically active platforms [31,32,33], anti-influenza activity of A-azepanodipterocarpol 8, azepanobetulin 12, azepanobetulin-28-cyclohexylcarboxamide 13, azepanoallobetulin 14, azepanouvaol 15 and azepanoglycyrrhetol 16 were tested and SI values from 1 to 3 was established. The combination of the A-azepano fragment and the dammarane frame led to the best results in terms of anti-influenza activity and only A-azepanodipterocarpol 8 showed a good level of IC50 1.1 μg ml–1 and SI 19 being a lead compound in this series.

Earlier, examples of the high antiviral activity of triterpenoid seco derivatives are presented [34,35,36,37,38,39]. Unfortunately, in contrast to the above data, 3,4-seco-3-amino-derivatives 16–19 were practically inactive against Flu A with SI values from 1 to 3. 3,4-Seco-3-amino-30-hydroxy-olean-12(13)-en 18 was a more active compound in this series with IC50 > 8.4 and SI 3. In this case, due to the small sample of compounds, it is impossible to say unequivocally about the inefficiency of the synthesis of seco-amino derivatives. It is also necessary to modify the 3-amino group of the fragment and further assessment of the structure-activity relationship of the obtained derivatives.

In summary, among tested nitrogen-containing lupane-, oleanane- and dammarane-based triterpenoids, azepanodipterocarpol 8 and 3β-amino-28-oxo-allobetulin 11 demonstrated a high inhibitory activity against H1N1 virus with IC50 1.1, 2.6 μg ml–1 and SI 19 and 10, respectively. It was established that introduction of A-azepano-ring fragment into dipterocarpol derivative with a native side chain results in an enhancing effect on the antiviral activity.

In conclusion, we have synthesized novel, previously unknown, derivatives of lupane-, oleanane-, and dammarane-based triterpenoids. Among them, dipterocarpol was shown to be a promising scaffold to produce novel N-containing bioactive derivatives including antiviral agents. Based on the results presented, focusing of the chemical library with further modification of A-azepanodipterocarpol in the side chain and synthesis of acylates on cycle A and study of structure-activity relation will lead to new effective compounds with high anti-viral activity.

Despite inspiring results, several questions should be addressed at the next stages of the characteristic of virus-inhibiting properties of triterpenes. First, in the present study we demonstrate the anti-viral potential of triterpenes against influenza virus based on the results of CPE reduction assay with two lead compounds, 8 and 11, identified. Their activity should be further studied by virus yield reduction assay to demonstrate their direct anti-viral action to rule out non-selective cytoprotective or antioxidant activity.

Second, in our experiments we used influenza virus A/PuertoRico/8/34 which is relatively old in terms of antigenic properties comparing to viruses currently circulating among humans. The spectrum of activity of lead compound 8 or its more active analog synthesized after focusing of chemical library, must be assessed using influenza viruses of A and B types, and different subtypes (H1, H3, H5, etc.) including contemporary isolates of influenza viruses.

Third, the virus we used in our study is resistant to adamantane derivatives, Rimantadine, the well-known blocker of virally encoded proton channel M2. This was confirmed by demonstrating the low activity of Rimantadine in our experiments (SI = 5, Table 1). The activity of triterpene derivatives 8 and 11 is higher suggesting that their target differs from M2 protein.

Finally, in the presented study we have demonstrated just the total virus-suppressing activity of compounds. The specific target and mechanism(s) of virus-inhibiting action of lead compounds as well as the ability of viral resistance development, should be assessed in further studies for possible development of novel antivirals. This will be a subject of further virology-oriented experiments.

Experimental

General

The spectra were recorded at the Center for the Collective Use “Chemistry” of the Ufa Institute of Chemistry of the UFRC RAS and RCCU “Agidel” of the UFRC RAS. 1H and 13C NMR spectra were recorded on a “Bruker AM-500” (Bruker, Billerica, MA, USA, 500 and 125.5 MHz respectively, δ, ppm, Hz) in CDCl3, internal standard tetramethylsilane. Mass spectra were obtained on a liquid chromatograph–mass spectrometer LCMS-2010 EV (Shimadzu, Kyoto, Japan). Melting points were detected on a micro table “Rapido PHMK05” (Nagema, Dresden, Germany). Optical rotations were measured on a polarimeter “Perkin-Elmer 241 MC” (Perkin Elmer, Waltham, MA, USA) in a tube length of 1 dm. Elemental analysis was performed on a Euro EA-3000 CHNS analyzer (Eurovector, Milan, Italy); the main standard is acetanilide. Thin-layer chromatography analyses were performed on Sorbfil plates (Sorbpolimer, Krasnodar, Russian Federation), using the solvent system chloroform-ethyl acetate, 40:1. Substances were detected by 10% H2SO4 with subsequent heating to 100–120 °C for 2–3 min. Compounds 1 [41], 2 [42], 3 [43], 9 [46], 10 [47], 11 [48], 12 [49], 13, 16, 18, 19 [50], 15 [51], 14 [52], 17 [53] were prepared by the literature methods. Dipterocarpol 3 was isolated from Dipteocarpus alatus collected in Quang Nam province of Vietnam and it spectral and physicochemical data was coincided with the literature [43]. Experimental details of new compounds relating to this paper are available in the Supplementary material (Figures S1–S9).

Chemistry

Synthesis of compounds (4–6)

To solution of CH3COONH4 (2 mmol, 0.8 g) in CH3OH (25 ml) NaBH3CN (0.6 mmol, 0.1 g) was added. The reaction mixture was stirred at 12 h at room temperature, on completion of the reaction 1М solution of NaOH (30 ml) was added, the precipitate was filtered off, washed until pH 7. The residue was purified by column chromatography on SiO2; the product was eluted with CHCl3, CHCl3-EtOH (from 40:1 to 40:3).

N-[3β-amino-lup-20(29)-en-28-oyl]cyclohexylamine (4)

Yield 86% (0.46 g); m. p. 124–125 °С; [α]D20 + 45° (с 0.1, CHCl3); δH (500.13 MHz, CDCl3) 0.75, 0.93, 0.98, 1.09, 1.12, 1.68 (6 s, 18H, CH3), 1.01–1.60 (m, 4H, СH2), 1.60–2.00 (m, 25H, CH, CH2, NH2), 2.17–2.19 (m, 5H, CH, CH2), 2.20 (dd, 1H, J = 3.8, J = 11.8, Hax-3), 2.40–2.52 (m, 2H, H16), 3.14 (td, 1H, J = 4.3, J = 11.2, H-19), 3.73 (m, 1H, H-1′), 4.57 and 4.72 (both br.s, 2H, H-29), 5.43 (d, 1H, J = 7.8, CONH); δC (125.76 MHz, CDCl3) 14.52, 15.63, 15.84, 19.49, 20.30, 21.77, 22.34, 24.90, 24.98, 25.64 (2 C), 29.29, 29.37, 29.68, 30.86, 32.93, 33.07, 33.28, 33.73, 36.55, 37.77, 38.44, 40.59, 42.51, 44.48, 45.27, 46.83, 47.70, 48.47, 50.04, 52.82, 55.43, 55.67 (C-3), 109.29, 151.01, 175.11 (CONH); MS (APCI) m/z 537.46 [M + H]+ (calcd for C36H60N2O, 536.46). Anal. Calcd for C36H60N2O: C, 80.54; H, 11.26; N, 5.22. Found: C, 80.23; H, 10.98; N, 5.03.

N-[3β-amino-olean-12(13)-en-28-oyl]-2-aminopyridineamine (5)

Yield 82% (0.43 g); m. p. 156–157°С; [α]D20 + 51° (с 0.1, CHCl3); δH (500.13 MHz, CDCl3) 0.63, 0.82, 0.87, 0.92, 0.93, 1.21 (6 s, 18H, CH3), 1.01–1.48 (m, 4H, СH2), 1.50–2.17 (m, 25H, CH, CH2, NH, NH2), 2.72 (dd, 1H, J = 4.3, J = 11.9, Hax-3), 5.53 (t, 1Н, J = 7.0, H-12), 6.90–8.31 (m, 4H, Harom); δC (125.76 MHz, CDCl3) 15.30, 15.80, 16.13, 17.17, 19.02, 19.50, 20.88, 21.23, 22.86, 24.92, 25.00, 25.66, 27.22, 29.36, 30.94, 32.96, 33.30, 33.79, 34.01, 37.27, 37.84, 38.48, 40.36, 40.83, 42.48, 46.90, 47.68, 50.14, 50.25, 55.43, 55.67 (C-3), 109.29, 151.01, 175.11 (CONH); MS (APCI) m/z 532.46 [M + H]+ (calcd for C35H53N3O, 531.42). Anal. Calcd for C35H53N3O: C, 79.05; H, 10.05; N, 7.90. Found: C, 78.95; H, 9.80; N, 7.76.

3β-Amino-20(S)-hydroxy-dammar-24-en (6)

Yield 89% (0.39 g); m. p. 168 °С; [α]D20 + 34° (с 0.1, CHCl3); δH (500.13 MHz, CDCl3) 0.73 (s, 3H, H-28), 0.74 (dd, 1H, 3J5-6ax = 11.7, 3J5-6eq = 2.2, H-5), 0.83 (s, 3H, H-19), 0.88 (s, 3H, H-30), 0.94 (s, 3H, H-29), 0.96 (s, 3H, H-18), 0.97 (ddd, 1H, 2J = 12.7, 3J1ax-2ax = 12.4, 3J1ax-2eq = 4.1, Hax-1), 1.06 (m, 1H, Hα-15), 1.14 (s, 3H, H-21), 1.23 (m, 1H, Hax-11), 1.26 (m, 1H, Hax-12), 1.27 (m, 1H, Heq-7), 1.33 (dd, 1H, 3J9-11ax = 11.6, 3J9-11eq = 2.8, H-9), 1.43 (m, 1H, Hax-6), 1.45 (tdd, 1H, 2J = 12.4, 3J2ax-1ax = 12.4, 3J2ax-3 = 11.9, 3J2ax-1eq = 3.6, Hax-2), 1.46 (m, 1H, Hβ-15), 1.47 (t, 2H, H-22), 1.49 (m, 1H, Hβ-16), 1.50 (m, 1H, Heq-11), 1.53 (m, 1H, Hax-7), 1.55 (dtd, 1H, 2J = 12.4, 3J2eq-3 = 4.1, 3J2eq-1ax = 4.1, 3J2eq-1eq = 3.6, Heq-2), 1.55 (m, 1H, Heq-6), 1.62 (d, 3H, 4J26-24 = 1.5, H-27), 1.63 (ddd, 1H, 3J13-17 = 12.6, 3J13-12ax = 10.2, 3J13-12eq = 3.5, H-13), 1.67 (dt, 1H, 2J = 12.7, 3J1eq-2ax = 3.6, 3J1eq-2eq = 3.6, Heq-1), 1.69 (d, 3H, 4J27-24 = 1.5, H-26), 1.72 (m, 1H, Hα-16), 1.74 (m, 1H, H-17), 1.82 (m, 1H, Heq-12), 2.04 (m, 1H, HA-23), 2.06 (m, 1H, HB-23), 2.34 (dd, 1H, 3J3-2ax = 11.9, 3J3-2eq = 4.1, H-3), 5.12 (m, 1H, 3J24-23 = 7.1, 4J24-26 = 1.5, 4J24-27 = 1.5, H-24); δC (125.76 MHz, CDCl3) 15.51 (C-28), 15.51 (C-18),16.13 (C-19),16.46 (C-30), 17.71 (C-27), 18.63 (C-6), 21.46 (C-11), 22.56 (C-23), 24.82 (C-16), 25.40 (C-21), 25.74 (C-26), 27.56 (C-12), 27.98 (C-2), 28.33 (C-29), 31.18 (C-15), 35.29 (C-7), 37.30 (C-10), 38.30 (C-4), 39.71 (C-1), 40.31 (C-8), 40.54 (C-22), 42.30 (C-13), 49.85 (C-17), 50.30 (C-14), 50.74 (C-9), 56.53 (C-5), 59.74 (C-3), 75.33 (C-20), 124.77 (C-24), 131.52 (C-25); δN (50.68 MHz, CDCl3) 31.06 (NH2); MS (APCI) m/z 444.76 [M + H]+ (calcd for C30H53NO, 443.76). Anal. Calcd for C30H53NO: C, 81.20; H, 12.04; N, 3.16. Found: C, 81.03; H, 11.98; N, 3.07.

3-Oxo-3a-aza-20(S)-hydroxy-dammar-24-en (7)

3-Oximino-dipterocarpol [43] (1 mmol, 0.44 g) in dry dioxane (15 ml) was treated with SOCl2 (0.4 ml), stirred at room temperature for 30 min, and poured into H2O (50 ml). The precipitate was filtered off and purified by column chromatography on SiO2 with n-C6H12, n-C6H12–EtOAc (4:1), and CHCl3 as eluents. Yield 0.41 g (82%), m.p. 261 °С, [α]D20 + 18° (с 0.1, CHCl3); δH (500.13 MHz, CDCl3) 0.80, 0.93, 0.98, 1.08, 1.16, 1.24, 1.55, 1.62 (8 s, 24H, 8CH3), 1.30–1.50 (m, 12Н, CH, CH2), 1.65–1.82 (m, 9Н, CH, CH2), 1.94–2.04 (m, 2H, H-23), 2.24–2.33 (m, 1H, Hax-2), 2.41–2.49 (m, 1H, Heq-2), 5.05 (t, 1Н, J = 6.8, Н-24), 5.68 (m, 1H, CONH); δC (125.76 MHz, CDCl3) 15.10, 16.14, 17.69, 18.17, 22.54 (2 C), 24.72, 25.42, 25.72, 27.28, 27.68, 30.99, 32.07, 33.23, 34.56, 39.59, 40.04, 40.02, 40.59, 42.37, 49.54, 50.25, 51.10 (2 C), 53.33, 56.20, 75.11 (C-20), 124.73 (C-24), 131.42 (C-25), 176.29 (CONH); MS (APCI) m/z 458.39 [M + H]+ (calcd for C30H51NO2, 457.39). Anal. Calcd for C30H51NO2: C, 78.72; H, 11.23; N, 3.05. Found: C, 78.43; H, 11.14; N, 2.98.

3-Deoxy-3а-homo-3a-aza-20(S)-hydroxy-dammar-24-en (8)

To a solution of compound 7 (1 mmol, 0.45 g) in dry THF (20 ml) (2.2 mmol, 0.07 g) LiAlH4 was added, and the mixture was refluxed for 1 h, then H2O (20 ml) and 10% HCl (10 ml) were added dropwise. The mixture was extracted with CHCl3 (3 × 20 ml), the organic layer was washed with water and dried over CaCl2. The solvent was removed under reduced pressure, the residue was purified by column chromatography on SiO2 with CHCl3, CHCl3-EtOH (50:1, 25:1) as eluents. Yield 62% (0.27 g); m.p. 102°С; [α]D20 + 114° (с 0.1, CHCl3); δH (500.13 MHz, CDCl3) 0.80, 0.96, 0.97, 1.03, 1.18, 1.21, 1.51, 1.60 (8 s, 24Н, 8СН3), 1.62–2.00 (m, 16Н, СН, СН2), 2.00-2.51 (m, 10H, СН, СН2), 3.19 (m, 2H, H-3), 5.51 (br.s, 1Н, Н-24); δC (125.76 MHz, CDCl3) 15.26, 15.63, 15.80, 17.72, 18.29, 22.48, 22.60, 25.15, 25.71, 27.02, 27.46, 28.84, 31.12, 32.08, 33.32, 34.12, 34.79, 39.72, 40.16, 40.33, 45.45, 47.52, 49.40, 51.47, 53.28, 56.22, 63.11, 75.33, 124.39 (C-24), 131.47 (C-25); MS (APCI) m/z 444.41 [M + H]+ (calcd for C30H53NO, 443.41). Anal. Calcd for C30H53NO: C, 81.20; H, 12.04; N, 3.16. Found: C, 81.01; H, 11.87; N, 3.03.

Biology

Viruses and cells

Influenza virus A/Puerto Rico/8/34 (H1N1) was obtained from the collection of viruses of St. Petersburg Pasteur Institute. Before the experiment, virus was propagated in the allantoic cavity of 10- to 12-day-old chicken embryos for 48 h at 36 °C. The infectious titer of the virus was determined in Madin-Darby Canine Kidney (MDCK) cells (ATCC # CCL-34) grown in 96-well plates in alpha-MEM medium with 10% fetal bovine serum.

Cytotoxicity assay

MDCK cells were seeded onto 96-well culture plates (104 cells per well) and incubated at 36 °C in 5% CO2 until continuous monolayer formation. To assess the toxicity of compounds, a series of their 3-fold dilutions at concentrations of 300 to 4 μg ml−1 in Eagle’s Minimal Essential Medium (MEM) were prepared. The dilutions were added to the wells of the plates. Cells were incubated for 72 h at 36 °C in a CO2 incubator under 5% CO2. Further, a microtetrazolium (MTT) assay was performed on 96-well plates. The cells were washed 2 times with saline (0.9% NaCl), and 100 μl/well of MTT solution [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] at a concentration of 0.5 μg ml−1 in MEM was added. The plates were incubated for 1 h at 36 °C, the liquid was removed, and dimethylsulfoxide (DMSO) (0.1 ml per well) was added. The optical density (OD) of the cells was measured on a Thermo Multiskan FC spectrophotometer (Thermo Fisher Scientific, USA) at a wavelength of 540 nm. Based on the obtained data, the CC50, the concentration of the compound that destroys 50% of the cells in the culture, was calculated for each specimen.

CPE reduction assay

The compounds in appropriate concentrations were added to MDCK cells (0.1 ml per well). MDCK cells were further infected with A/Puerto Rico/8/34 (H1N1) influenza virus (m.o.i 0.01). Plates were incubated for 72 h at 36 °C at 5% CO2. After that, cell viability was assessed by the MTT test, as described above. The cytoprotective activity of compounds was considered as their ability to increase the values of the OD compared to the control wells (with virus only; no drugs). Based on the obtained results, the IC50 values, i.e., the concentration of compounds that results in 50% cell protection, were calculated using GraphPad Prism software. IC50 values in μg ml−1 were then calculated into micromoles. For each compound, the value of the selectivity index (SI) was calculated as a ratio of CC50 to IC50.

Conclusions

In conclusion, the synthesis and evaluation of the in vitro anti-influenza activities of lupane, oleanane, and dammarane type A-amino derivatives was performed. The primary assay of tested triterpenoids against Flu A H1N1 demonstrated their SI values ranged from 1 to 19. Dammarane type A-azepanodipterocarpol showed the most significant antiviral activity against the pandemic influenza A virus (H1N1), with an IC50 value of 1.1 μM and SI 19.